Cargando…
Deregulation of mitochondrial F1FO-ATP synthase via OSCP in Alzheimer’s disease
F1FO-ATP synthase is critical for mitochondrial functions. The deregulation of this enzyme results in dampened mitochondrial oxidative phosphorylation (OXPHOS) and activated mitochondrial permeability transition (mPT), defects which accompany Alzheimer’s disease (AD). However, the molecular mechanis...
Autores principales: | Beck, Simon J., Guo, Lan, Phensy, Aarron, Tian, Jing, Wang, Lu, Tandon, Neha, Gauba, Esha, Lu, Lin, Pascual, Juan M., Kroener, Sven, Du, Heng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494197/ https://www.ncbi.nlm.nih.gov/pubmed/27151236 http://dx.doi.org/10.1038/ncomms11483 |
Ejemplares similares
-
Delay-Period Activity and Executive Functions of the Prefrontal Cortex
por: Phensy, Aarron, et al.
Publicado: (2019) -
The mitochondrial inhibitor IF1 binds to the ATP synthase OSCP subunit and protects cancer cells from apoptosis
por: Galber, Chiara, et al.
Publicado: (2023) -
Antioxidant Treatment in Male Mice Prevents Mitochondrial and Synaptic Changes in an NMDA Receptor Dysfunction Model of Schizophrenia
por: Phensy, Aarron, et al.
Publicado: (2017) -
Caspase inhibition rescues F1Fo ATP synthase dysfunction-mediated dendritic spine elimination
por: Chen, Hao, et al.
Publicado: (2020) -
Antioxidant Treatment with N-acetyl Cysteine Prevents the Development of Cognitive and Social Behavioral Deficits that Result from Perinatal Ketamine Treatment
por: Phensy, Aarron, et al.
Publicado: (2017)